Agree 100 percent stockrock. I allocated a sum of money 5 months ago and bought into CHM. But the more I research the more I buy LOL. As CHM continues buying up new IP, and I research it and then buy more. Now with the new NK platform I have topped up in a big way, three times more than I originally allocated. I did the same thing a few years ago with that other bio stock that's been killing it this year. That other stock may have different IP platforms than CHM, but the company strategy is the same because of Paul Hopper. Buy the best IP that money can buy, and has already been proven in a lab. Get the best people/pros in the world to develop it. And make sure you have plenty shots on goal. This is now Paul Hoppers new formula over the last couple of years, and he is killing it.
CHM Price at posting:
26.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)